Role of ECM in tissue architecture and signaling
Adipose tissue used in autologous regenerative procedures is structurally organized as aggregates of mature adipocytes embedded within an extracellular matrix (ECM), together with stromal vascular fraction (SVF) cells and vascular elements. Microscopy of lipoaspirate harvested with small-port cannulas shows large aggregates of adipocytes and ECM, indicating that the tissue is not a simple suspension of isolated cells but a complex three-dimensional structure in which cells remain partially entrapped within matrix components. This architecture is relevant for autologous regeneration because it preserves native cell–matrix relationships that may influence cell survival and function after grafting.
Analytical fractionation of micro-fragmented adipose tissue with non-invasive technologies has further highlighted the structural contribution of ECM. In these preparations, the heaviest fractions elute as large cell aggregates composed of adipocytes and ECM, while lighter fractions contain small fat droplets, red blood cells, single cells, and ECM fragments. The presence of ECM fragments across fractions suggests that mechanical harvesting and processing liberate matrix components of different sizes, which remain associated with stromal and vascular cells. This distribution underlines the role of ECM as a structural backbone that organizes adipocytes and stromal cells into discrete clusters suitable for injection.
The ECM also contributes indirectly to the signaling milieu experienced by adipose-derived stromal cells (ASCs) and other SVF components. Adipose tissue is recognized as a source of multipotent mesenchymal stromal/stem cells capable of differentiating into osteogenic, chondrogenic, myogenic, hepatogenic, and endothelial lineages, and of secreting bioactive molecules with angiogenic, antifibrotic, antiapoptotic, and immunomodulatory properties. Within native adipose tissue, these cells reside in close association with perivascular structures and ECM, which provides mechanical support and binding sites that can modulate exposure to cytokines and growth factors. Although the specific molecular interactions are not detailed in the available data, the maintenance of adipocyte–ECM–SVF aggregates implies preservation of a microenvironment that supports stromal cell function.
Studies on decellularized matrices derived from mesenchymal stem cells, cited within the characterization of adipose tissue for facial aging treatment, indicate that extracellular matrices can influence mesenchymal stem cell proliferation, migration, and multilineage differentiation potential. These observations support the concept that ECM is not only a passive scaffold but also a regulator of cell behavior. In the context of autologous adipose grafts, retaining ECM within micro-fragmented tissue may therefore help maintain a favorable niche for ASCs and other stromal cells, with implications for their regenerative activity after implantation.
ECM as a biological scaffold
Micro-fragmented adipose tissue harvested with dedicated systems such as SEFFI and micro-SEFFI is explicitly designed to deliver viable adipocytes together with SVF/ASCs in a structural context that includes ECM aggregates. Microscopy and fractionation analyses demonstrate that these preparations contain large adipocyte–ECM aggregates as well as ECM fragments, confirming that the matrix is preserved as a physical framework. This framework can be regarded as a biological scaffold that maintains tissue integrity during handling and injection and supports the spatial organization of stromal cells at the recipient site.
The biological scaffold function of ECM is also evident in studies of adipose tissue harvested with small-port microcannulas, where tissue samples show a complex structure with many cells entrapped in the extracellular matrix. Cell viability assays indicate that cells released from the harvesting procedure and cells remaining within the ECM are vital and metabolically active over time, suggesting that the matrix provides a supportive environment that protects and sustains embedded cells. This is consistent with the concept that ECM-based scaffolds can enhance cell survival by providing mechanical support and maintaining cell–cell and cell–matrix contacts.
In the context of autologous regenerative therapy, adipose tissue grafts are used not only as a source of cells but also as a structural filler. Clinical applications in aesthetic rejuvenation and soft-tissue restoration rely on adipose tissue implantation to improve skin trophism, accelerate closure of complex wounds or ulcers, and enhance skin appearance after radiotherapy damage. These effects are attributed to the combined action of adipocytes, SVF cells, and their secreted factors, but they also depend on the ability of the transplanted tissue to integrate structurally with host tissues. The preserved ECM within the graft acts as a natural scaffold that can be molded and distributed in superficial planes, supporting both volumization and regenerative outcomes.
The notion of ECM as a biologically active scaffold is further supported by references to marrow-derived extracellular matrix systems used ex vivo to expand highly functional human mesenchymal stem cells, and to decellularized matrices that modulate mesenchymal stem cell behavior. These data, cited in the context of adipose tissue characterization, reinforce the translational relevance of matrix-based scaffolds. In autologous adipose grafting, the native ECM present in micro-fragmented tissue can be viewed as an intrinsic scaffold that obviates the need for exogenous biomaterials, while still providing structural and regulatory cues to resident stromal cells.
Interaction with stromal cells
The stromal vascular fraction of adipose tissue contains adipose-derived stromal cells, pericytes, endothelial progenitor cells, and other interrelated cell populations that reside in close association with vascular and matrix structures. ASCs are defined as plastic-adherent multipotent cells capable of differentiating towards osteoblasts, adipocytes, and chondrocytes, and they express mesodermal markers while lacking hematopoietic markers. Within the intact tissue, these cells are embedded in or adjacent to ECM, which provides a three-dimensional context for their proliferation and differentiation. The preservation of adipocyte–ECM–SVF aggregates in micro-fragmented grafts therefore maintains the native spatial relationship between stromal cells and matrix.
Stromal cells and pericytes in adipose tissue secrete a wide variety of factors with anti-fibrotic, anti-apoptotic, immunomodulatory, and neo-vascularization properties. These trophic activities are central to the regenerative potential of autologous adipose grafts. The ECM can modulate these functions by influencing cell adhesion, mechanical tension, and exposure to soluble mediators. Although specific signaling pathways are not detailed in the available documents, the observation that stromal cells remain viable and proliferative when entrapped within ECM-rich aggregates suggests that the matrix supports their secretory and paracrine roles after transplantation.
Experimental characterization of lipoaspirate-derived ASCs from SEFFI and micro-SEFFI systems shows that these cells retain a classical mesenchymal morphology, form colony-forming units, and display robust proliferation and multilineage differentiation capacity, regardless of the cannula size used for harvesting. Even when micro-fragmented tissue exhibits small sizes and relatively low cellularity, stem cells can still be isolated and expanded, indicating that the harvesting process preserves functional stromal cells within the ECM framework. This supports the view that ECM–stromal cell interactions are maintained sufficiently to sustain cell viability and stemness characteristics.
In clinical applications such as intra-articular injection of autologous micro-fragmented adipose tissue for osteoarthritis, the regenerative effect is attributed to adipose-derived stem cells, cytokines, growth factors, pre-adipocytes, and mature adipocytes contained within the graft. These components are delivered together with their native ECM, which likely influences how stromal cells interact with the joint environment. Autologous regenerative therapy is described as utilizing the patient’s own mesenchymal cells in a single procedure, with their differentiation depending on signals from the surrounding environment and specific growth factors. The ECM within the graft forms part of this environment, shaping stromal cell responses in situ.
Contribution to repair and regeneration
Regenerative therapies based on the injection of micro-fragmented adipose tissue are considered promising for degenerative diseases and disorders that are not adequately managed by conventional care, as well as for antiaging indications. The therapeutic effect is linked to the properties of SVF cells naturally present in adipose tissue, particularly mesenchymal stem cells that exhibit differentiation potential and secrete bioactive molecules. Within this context, the ECM contributes by providing a structural and biochemical milieu that supports the survival and function of these cells after grafting, thereby facilitating tissue repair and regeneration.
Clinical experiences with autologous micro-fragmented adipose tissue in osteoarthritis report improvements in pain, range of motion, stiffness, and quality of life following intra-articular injection of fat micrografts. These outcomes are interpreted as the result of a reparative effect of autologous fat graft on damaged tissue, combined with a lubricating effect within the joint. The grafts deliver adipocytes, ADSCs, and other SVF components within an ECM-rich matrix, which may help stabilize the injected material, localize stromal cells, and support their paracrine activity in the articular environment.
In cutaneous and soft-tissue applications, adipose tissue implantation has been used to improve skin trophism, accelerate closure of complex wounds or ulcers, and enhance the appearance of skin damaged by radiotherapy. These effects are associated with the angiogenic, antifibrotic, and immunomodulatory characteristics of adipose-derived mesenchymal cells and their capacity to stimulate revascularization of fat grafts. The ECM within the graft provides a scaffold for neovascular ingrowth and supports the organization of regenerating tissue, contributing structurally to the repair process while stromal cells exert trophic and immunomodulatory effects.
The regenerative contribution of ECM-associated stromal cells is also highlighted in facial aging treatments using SEFFI and micro-SEFFI systems. These techniques harvest adipose tissue designed to restore and regenerate tissue by delivering viable adipocytes and SVF/ASCs in a form suitable for superficial injection. Despite the small size and lower cellularity of micro-SEFFI-derived tissue, stem cells can be isolated and are thought to assist with tissue regeneration once re-injected. The presence of ECM fragments and aggregates in these preparations suggests that the matrix plays a role in maintaining graft integrity and supporting regenerative interactions with the host dermal and subdermal tissues.
Preservation during processing
The way adipose tissue is harvested and processed has direct implications for the preservation of ECM and associated cells. Minimally invasive techniques using guided microcannulas with small side-port holes (0.8 and 1 mm) allow harvesting of adipose tissue without additional chemical or mechanical manipulation. Studies comparing these methods with standard liposuction followed by enzymatic digestion show that microcannula-harvested tissue contains viable and proliferative cells entrapped in the extracellular matrix, with cell viability increasing over 72 hours in culture. These findings indicate that the ECM structure is sufficiently preserved to support cell survival after harvesting.
Enzymatic digestion with collagenase, used to isolate SVF cells, disrupts the extracellular matrix and the binding of adipocytes and other cells. While this method is effective for obtaining isolated stromal cells, it removes the native ECM scaffold and is subject to regulatory constraints in some settings. In contrast, mechanical harvesting with small-port cannulas avoids enzymatic disruption, maintaining adipocyte–ECM–SVF aggregates that can be used directly as a tissue graft. This approach aligns with the concept of minimal manipulation, preserving the structural and cellular components of the tissue in a form closer to its physiological state.
Characterization of tissue harvested with SEFFI and micro-SEFFI systems using microscopy and Celector-based fractionation confirms that these procedures yield samples with defined fluidity and composition, including red blood cell contamination, cell aggregates, and extracellular matrix fragments. The ability to visualize and quantify ECM fragments and aggregates provides a quality control framework for assessing how well the matrix is preserved during processing. Despite smaller aggregate size and lower cellularity in micro-SEFFI-derived tissue, stem cells with mesenchymal characteristics can still be isolated, indicating that essential ECM–cell relationships are maintained.
Comparative analyses of cannula designs show that adipose tissue harvested with small side-port cannulas yields a comparable amount of viable cells to tissue harvested with larger-port liposuction cannulas and processed enzymatically. In these experiments, the tissue harvested with 0.8 and 1 mm side-port holes exhibited higher initial absorbance due to single cells released by the mechanical action of the cannula, while still containing many cells within a complex ECM structure. These data support the use of microcannula-based harvesting to preserve ECM and cell viability without resorting to enzymatic digestion, thereby maintaining a matrix-rich graft suitable for autologous regenerative applications.
Implications for clinical efficacy
The preservation of ECM within autologous adipose grafts has several implications for clinical efficacy in regenerative medicine. Micro-fragmented adipose tissue harvested with minimally invasive, minimally manipulative techniques is described as a promising source for regenerative treatments, with viable and proliferative cells remaining entrapped in the extracellular matrix. By maintaining the native tissue architecture, including ECM, adipocytes, and SVF cells, these grafts can be delivered in a form that supports both structural integration and biological activity at the target site.
In osteoarthritis management, intra-articular injection of autologous fat micrografts has been associated with improvements in pain, range of motion, and stiffness, with many patients reporting satisfaction and a perceived improvement in quality of life. Autologous regenerative therapy in this setting utilizes the patient’s own mesenchymal cells in a single procedure, relying on their capacity to respond to environmental signals and growth factors. The ECM within the injected micrograft likely contributes to the stability and localization of the graft, supporting stromal cell survival and function within the joint and potentially influencing the duration and magnitude of clinical benefit.
In aesthetic and dermatologic indications, adipose tissue grafts rich in ECM and stromal cells are used for facial rejuvenation and treatment of aging-related changes. SEFFI and micro-SEFFI systems are designed to provide tissue suitable for superficial injection, delivering viable adipocytes and SVF/ASCs in small aggregates that integrate into the subdermal plane. The presence of ECM fragments and aggregates in these preparations is thought to partially explain the regenerative potential of micro-SEFFI tissue grafts, as stromal cells re-injected with their native matrix can assist with tissue regeneration and improvement of skin quality.
Overall, the available evidence indicates that techniques which preserve the extracellular matrix while maintaining high cell viability—such as microcannula-based harvesting without enzymatic digestion—provide adipose tissue grafts that are structurally and biologically suited for autologous regeneration. The ECM functions as both a scaffold and a regulator of stromal cell behavior, and its conservation during processing appears to be an important factor in the observed clinical outcomes across orthopedic, reconstructive, and aesthetic applications of autologous adipose tissue.
Sources (Bibliography)
- Gennai A. Comparison of Harvesting and Processing Technique for Adipose Tissue Graft: Evaluation of Cell Viability, 2021.
- Rossi M. Characterization of Tissue and Stromal Cell Components in Adipose Grafts for Facial Aging Treatment, 2020.
- Trentani P, Meredi E, Zarantonello P, Gennai A. Role of Autologous Micro-Fragmented Adipose Tissue in Osteoarthritis Treatment. J Pers Med, 2024.